TORM Expands Fleet With Strategic Vessel Purchase
Torm to Buy Eight Product Tankers in $340M Cash and Stock Deal
Kepler Capital Maintains Torm(TRMD.US) With Buy Rating, Raises Target Price to $44.38
Kepler Capital analyst Axel Styrman maintains $Torm(TRMD.US)$ with a buy rating, and adjusts the target price from $43.09 to $44.38.According to TipRanks data, the analyst has a success rate of 62.9%
Kepler Capital Sticks to Their Buy Rating for Torm (TRMD)
Shipping Company Shares Sink on Possible Slowing of Red Sea Hostilities
Kepler Capital Maintains Torm(TRMD.US) With Buy Rating, Raises Target Price to $43.87
Kepler Capital analyst Axel Styrman maintains $Torm(TRMD.US)$ with a buy rating, and adjusts the target price from $41.19 to $43.87.According to TipRanks data, the analyst has a success rate of 68.5%
OCM Njord Closes Secondary Public Offer of Torm Shares
Torm (TRMD-A.CO) said Monday that OCM Njord Holdings closed its secondary public offering of class A shares of the refined oil products company. OCM Njord, indirectly owned by funds managed by Oaktree
TORM Launches Major Secondary Share Offering
TORM Announces Capital Boost With New Shares
Cathay Pacific Junan: The profit center of 24Q1 tanker owners will continue to rise and continue to be optimistic about oil transportation super bull market options
The capacity utilization rate of the oil transportation market has reached a threshold. It is expected that supply and demand will continue to improve in the next few years, and the rise and continuation of the boom will exceed expectations, so strategic attention should be paid.
TORM Announces Capital Increase With New Shares
TORM A/S Executes Share Capital Increase
Torm A/S Posts Strong Q1 2024 Earnings Growth
Torm | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Torm PLC : Jefferies Initiates Coverage With Buy Rating; Price Target $42
TORM Plc Expands Capital With New Tanker Acquisition
NXPL, MGRM and OCX Among Pre-market Losers
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) fell sharply in today's pre-market trading a
TORM Goes Ex Dividend Monday
TORM A/S Shareholders Approve Key Resolutions